Press release
Biopharma PEG Scientific Inc. to Showcase Comprehensive PEG Derivative Portfolio at TIDES USA 2025
Biopharma PEG offers a comprehensive portfolio of over 4,000 PEG derivatives, including monodispersed, polydispersed, and multi-arm PEGs, available in quantities from milligrams to 100 kilograms. Their diverse product line supports critical applications in the biopharmaceutical industry, including:
PEGylation: Enhancing drug efficacy and delivery.
LNP-based drug delivery: Facilitating the development of lipid nanoparticle formulations.
ADC therapy: Providing essential linkers for antibody-drug conjugates.
PROTAC development: Enabling the creation of proteolysis-targeting chimeras.
Hydrogels: Supporting tissue engineering and drug delivery matrices.
Diagnostics: Contributing to advanced diagnostic tools and assays.
"We are excited to connect with the TIDES community and showcase our broad spectrum of PEG derivatives," said Sonia Lee, Head of Business Development at Biopharma PEG. "Our commitment to providing both catalog and custom PEG solutions, manufactured under stringent GMP conditions, ensures that our partners receive the highest quality materials to accelerate their innovative work."
At Booth #913, visitors can:
Explore a Wide Range of Catalog PEGs: Discover readily available products for rapid project initiation
Discuss Custom Synthesis Capabilities: Learn how Biopharma PEG can tailor PEG solutions to meet specific project requirements.
Understand GMP-Grade Manufacturing: Gain insights into the company's commitment to quality and consistency.
Engage with the Biopharma PEG Team: Discuss specific project needs and explore potential collaborations.
Biopharma PEG encourages attendees to schedule dedicated meeting times during TIDES USA 2025 to ensure personalized discussions. Please contact sales@biochempeg.com to arrange a meeting or feel free to visit Booth #913 at your convenience.
Biopharma PEG Scientific Inc.
108 Water Street, Suite 4D, Watertown, MA 02472, USA
TEL: 1-857-928-2050 / 1-857-366-6766
Fax: 617-206-9595
Email: sales@biochempeg.com
Biopharma PEG Scientific Inc. is a leading global provider of high-quality GMP-grade polyethylene glycol (PEG) derivatives, offering a comprehensive catalog of over 4,000 products alongside custom synthesis services. We specialize in supporting critical biopharmaceutical applications such as PEGylation, LNP drug delivery, ADC therapy, PROTAC development, hydrogels, and diagnostics. Committed to quality and innovation, Biopharma PEG partners with researchers and developers worldwide, providing reliable PEG solutions in quantities from milligrams to kilograms to accelerate the advancement of life-changing therapeutics and diagnostics.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Biopharma PEG Scientific Inc. to Showcase Comprehensive PEG Derivative Portfolio at TIDES USA 2025 here
News-ID: 3993565 • Views: …
More Releases from Biopharma PEG Scientific Inc
BIOPHARMA PEG Receives FDA DMF Listings for Two Key PEG Derivatives
BIOPHARMA PEG, a leading developer and supplier of high-purity polyethylene glycol (PEG) derivatives, today announced that two of its proprietary products-mPEG-pALD 20K and HZ-PEG-HZ (1K)-have successfully passed FDA review and are now listed in the U.S. Drug Master File (DMF) database.
mPEG-pALD (20K) - DMF No. 040600
HZ-PEG-HZ (1K) - DMF No. 041864
These new listings mark a significant step in BIOPHARMA PEG's ongoing efforts to provide regulatory-ready, high-quality PEG solutions to the…
Monodispersed PEG Linkers Enhance Antibody-Drug Conjugates (ADCs)
Antibody-drug conjugates (ADCs) combine potent small-molecule drugs with monoclonal antibodies for targeted cancer therapy. A major challenge is loading enough drug onto each antibody without compromising solubility or circulation time. Introducing polyethylene glycol (PEG) linkers between the antibody and drug payload can address this. PEG is hydrophilic, biologically inert, and FDA‐recognized as safe. As a flexible spacer, PEG "shields" the hydrophobic drug, greatly improving ADC solubility and stability. In fact,…
BIOPHARMA PEG Showcases DSPE-PEG-Mannose: A Cutting-Edge Polymer for Drug Delive …
Watertown, MA - March 24, 2025 - Biopharma PEG, a leading supplier of high-quality polyethylene glycol (PEG) derivatives, highlights its innovative product DSPE-PEG-Mannose, an advanced biomedical polymer with significant potential in drug delivery, tumor-targeted therapy, tissue recognition, and adhesion.
Structural Advantages of DSPE-PEG-Mannose
DSPE-PEG-Mannose is composed of three key components that enable its diverse applications:
DSPE (1,2-Distearoyl-sn-glycero-3-phosphoethanolamine): A phospholipid with amphiphilic properties, forming stable micelles in aqueous solutions.
PEG (Polyethylene Glycol): A biocompatible polymer…
Biopharma PEG Announces FDA DMF Registration for mPEG-pAld (20K)
Biopharma PEG, a leading manufacturer of high-quality polyethylene glycol (PEG) derivatives, today announced that its mPEG-pAld (20K) product has successfully achieved DMF (Drug Master File) II registration with the U.S. Food and Drug Administration (FDA) under DMF number 040600.
"We are thrilled to receive FDA DMF registration for our mPEG-pAld (20K) product," said Sonia Lee, Marketing Director at Biopharma PEG. "This achievement demonstrates our commitment to providing our customers with the…
More Releases for GMP
Creative Peptides Released GMP Synthesis Service
Located in Shirley, New York, the world’s leading peptide supplier Creative Peptides announced the launch of its GMP synthesis (https://www.creative-peptides.com/services/custom-gmp-peptide-synthesis-services.html ) business on August 29, 2018. Now this company is focused on the development and GMP manufacturing of pharmaceutical grade peptides.
As the demand of pharmaceutical market continues to grow, more and more pharmas and research institutions choose the CMO and CRO models to expand their businesses, which is more…
Diapharm implements European GMP guidelines in China
Münster (DE), London (UK), Ningbo (CN), 20 December 2013 – Pharmaceutical service provider Diapharm (diapharm.com) is increasing its business activities in China: Diapharm has now implemented a “European” quality management system for Neptune Pharma Ltd (www.neptunepharma.com) in their Joint Venture Partner’s factory in Ningbo, Zhejiang Province. And it has done so successfully: The veterinary medicinal product Trident 500mg/g Powder for Suspension for Fish Treatment (www.trident-50.com), is manufactured onsite under EU…
ECA Foundation releases free GMP WebApp
The ECA Foundation has been providing advanced training and information services in the pharmaceutical industry and especially with regard to pharmaceutical Quality Assurance and GMP compliance for more than 10 years. Now the organisation took advantage of its extensive experience to develop a further free of charge service – the new GMP WebApp.
This new GMP WebApp runs on all smartphones and tablet PCs (Apple and Android platforms) and allows users…
GMP Friction Products Awarded ISO 9001:2008
Internationally Recognized Certification Measures Consistency in Process, Procedure and Quality Performance in Manufacture of Friction Materials
AKRON, OH (March 23, 2011) -- GMP Friction Products, a world leader manufacturing powdered metal friction products for clutch plates and brake pads, recently received certification for ISO 9001:2008.
“ISO 9001:2008 signifies we have taken the extra measure of documenting the policies and standards to ensure consistent compliance with our manufacturing processes,” said Jerry Lynch,…
GMP MANUAL Volume 2 - Validation Procedures by Maas & Peither AG – GMP Publish …
GMP Publishing is launching its new GMP MANUAL Volume 2 – Validation Procedures.
The compendium on validation procedures was written by Dr. Doris Borchert, Dr. Peter Bosshard, Dr. Ralph Gomez, Dr. Michael Hiob, Dr. Christine Oechslein, Max Lazar, Ulrike Reuter, Michael Schulte, Uwe Schwarzat – all international experts and key opinion leaders. They share their detailed understanding of the various aspects of the validation process in clear and comprehensive style…
blue inspection body celebrates 50 GMP audits
Münster (Germany), 20 November 2009. Two years after founding the company and just 18 months after gaining the accreditation blue inspection body GmbH announced today the successful execution of its 50th GMP audit. Further audit trips to China, India, Israel and various European countries have been scheduled already, meaning that in the first quarter 2010 the 75th audit is targeted to be completed. Blue, as a privately organised inspection body,…
